Axon Enterprise, Inc. (NASDAQ:AXON) Shares Purchased by LPL Financial LLC

LPL Financial LLC raised its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 13.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 101,431 shares of the biotechnology company’s stock after purchasing an additional 12,052 shares during the quarter. LPL Financial LLC’s holdings in Axon Enterprise were worth $60,282,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Daiwa Securities Group Inc. increased its position in Axon Enterprise by 10.9% in the 3rd quarter. Daiwa Securities Group Inc. now owns 9,927 shares of the biotechnology company’s stock valued at $3,967,000 after acquiring an additional 973 shares during the period. DRW Securities LLC bought a new position in shares of Axon Enterprise in the third quarter worth $291,000. The Manufacturers Life Insurance Company increased its holdings in shares of Axon Enterprise by 0.6% during the third quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company’s stock valued at $17,440,000 after purchasing an additional 276 shares during the period. Dai ichi Life Insurance Company Ltd raised its stake in shares of Axon Enterprise by 63.6% during the third quarter. Dai ichi Life Insurance Company Ltd now owns 3,646 shares of the biotechnology company’s stock valued at $1,457,000 after purchasing an additional 1,418 shares in the last quarter. Finally, D.A. Davidson & CO. lifted its holdings in Axon Enterprise by 0.3% in the third quarter. D.A. Davidson & CO. now owns 12,622 shares of the biotechnology company’s stock worth $5,044,000 after purchasing an additional 44 shares during the period. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 3.1 %

Shares of AXON opened at $559.06 on Thursday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The stock has a market capitalization of $42.84 billion, a P/E ratio of 144.46, a P/E/G ratio of 5.17 and a beta of 1.12. The business’s 50-day moving average price is $591.51 and its 200 day moving average price is $546.76.

Analysts Set New Price Targets

AXON has been the topic of several research analyst reports. Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Finally, The Goldman Sachs Group boosted their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $604.67.

Insider Transactions at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.